Life ScienceCompany
Longboard Pharmaceuticals Ownership
Who owns Longboard Pharmaceuticals?
Longboard Pharmaceuticals is owned by H. Lundbeck A/S. It was acquired on October 14, 2024.
Was Longboard Pharmaceuticals formerly PE-backed?
Yes. Longboard Pharmaceuticals was formerly owned by 1 private investor.
Longboard Pharmaceuticals Business Overview
Where is Longboard Pharmaceuticals headquartered?
Longboard Pharmaceuticals is headquartered in La Jolla, California.
What is Longboard Pharmaceuticals’ revenue?
Longboard Pharmaceuticals disclosed revenue of 57M USD for 2023 and 45M USD for 2022.
What sector is Longboard Pharmaceuticals in?
Longboard Pharmaceuticals is a life science company.
When was Longboard Pharmaceuticals founded?
Longboard Pharmaceuticals was founded in 2020.
Life Science M&A Summary in 2024
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.
Join Mergr to view all 186 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 172 by strategics.